1. Home /
    2. Altai Protocol Library /
  2. New Drug: Naxitamab for neuroblastoma

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara
Altai Protocol Library

New Drug: Naxitamab for neuroblastoma

New Drug: Naxitamab for neuroblastoma
Study:
  • Open label, single arm (Study 201)
  • Refractory or relapsed high-risk neuroblastoma in the bone or bone marrow with a documented partial response, minor response, or stable disease to prior therapy
  • Naxitamab with GM-CSF (n=22)
Efficacy:
  • ORR: 45% [24%-68%], CR: 36%, PR: 9%
  • Median DoR: 6.2 mos [4.9 – NE]
Safety:
  • Grade 3-4 AEs: Pain (72%), infusion-related reaction (68%), anaphylactic reaction (12%), diarrhea (8%)
Not published yet (Nov 2020)
FDA package insert

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More